首页> 外文期刊>Cornea >A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
【24h】

A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.

机译:一例结膜角膜上皮内瘤样变成功应用局部丝裂霉素C和干扰素α-2b周期治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

SUMMARY: PURPOSE To report a case of conjunctiva-cornea intraepithelial neoplasia (CCIN) treated with topical mitomycin C (MMC) and interferon alfa-2b in cycles.METHODS A 52-year-old woman referred for limbal stem cell deficiency and epithelial defect was found instead to have CCIN. The diagnosis was confirmed by impression cytology and treated in cycles with topical 0.02% MMC for 14 days in the first cycle, 12 days in the second cycle, and 3 days in the third cycle followed by topical interferon alfa-2b 1 x 106 U/mL for 11 days.RESULT Topical MMC for 2.5 cycles resulted in 95% reduction of CCIN and improvement of 2 lines of vision. Because of intolerance to MMC, she was switched to topical interferon alfa-2b for 11 days, resulting in total resolution of CCIN, which lasted for at least 10 months.CONCLUSIONS After differentiation from a persistent corneal epithelial defect and limbal stem cell deficiency by dye staining and impression cytology, the patient in this case of CCIN was successfully treated with topical MMC and interferon alfa-2b in cycles.
机译:摘要:目的报道周期性丝裂霉素C(MMC)和干扰素α-2b联合治疗结膜角膜上皮内瘤样病变(CCIN)的方法。方法:一名52岁妇女因角膜缘干细胞缺乏和上皮缺陷而被称为而是找到了CCIN。诊断是通过印记细胞学证实的,并在第一个周期中先后用局部0.02%MMC周期治疗14天,第二个周期治疗12天,第三个周期治疗3天,然后局部使用干扰素alfa-2b 1 x 106 U /结果11毫升。结果局部MMC进行2.5个循环可导致CCIN降低95%,并改善2条视线。由于对MMC的耐受性差,她改用局部干扰素alfa-2b治疗11天,导致CCIN完全消退,持续至少10个月。染色和印象细胞学检查,这种情况下的CCIN患者已成功地局部用MMC和α-2b干扰素治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号